InfuSystem Holdings (INFU) EBIT Margin (2010 - 2026)
InfuSystem Holdings (INFU) posted EBIT Margin of 4.72% for Q1 2026, down 53.95% on a QoQ basis from 10.25% in Q4 2025, and up 294.0% year-over-year from 1.2% in Q1 2025.
InfuSystem Holdings (INFU) EBIT Margin (2010 - 2026) Analysis & Trends
InfuSystem Holdings' EBIT Margin history runs 17 years deep, the most recent figure standing at 4.72% for Q1 2026.
- Quarterly EBIT Margin rose 294.0% year-over-year to 4.72% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 9.05% (up 298.0% YoY) and the FY2025 annual result came in at 8.31%, up 320.0% from the prior year.
- EBIT Margin was 4.72% for Q1 2026 at InfuSystem Holdings, down from 10.25% in the prior quarter.
- Across five years, EBIT Margin topped out at 10.49% in Q2 2025 and bottomed at 2.64% in Q1 2024.
- A 5-year average of 4.48% and a median of 3.93% in 2023 frame the typical range for EBIT Margin.
- Annual changes were most pronounced in 2022 — EBIT Margin sank 553 bps — and 2025, when it jumped 499 bps.
- InfuSystem Holdings' EBIT Margin stood at 3.57% in 2022, then increased by 10 bps to 3.93% in 2023, then soared by 96 bps to 7.73% in 2024, then jumped by 33 bps to 10.25% in 2025, then plunged by 54 bps to 4.72% in 2026.
- Business Quant data shows INFU's EBIT Margin at 4.72% in Q1 2026, 10.25% in Q4 2025, and 10.44% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn | 4.72% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.72% |
| Dec 31, 2025 | 10.25% |
| Sep 30, 2025 | 10.44% |
| Jun 30, 2025 | 10.49% |
| Mar 31, 2025 | 1.78% |
| Dec 31, 2024 | 7.73% |
| Sep 30, 2024 | 9.24% |
| Jun 30, 2024 | 5.50% |
| Mar 31, 2024 | -2.64% |
| Dec 31, 2023 | 3.93% |
| Sep 30, 2023 | 5.32% |
| Jun 30, 2023 | 3.93% |
| Mar 31, 2023 | -0.35% |
| Dec 31, 2022 | 3.57% |
| Sep 30, 2022 | 3.46% |
| Jun 30, 2022 | 0.77% |
| Mar 31, 2022 | -1.96% |
| Dec 31, 2021 | 6.04% |
| Sep 30, 2021 | -1.32% |
| Jun 30, 2021 | 2.80% |